Related Experiment Video
Updated: Dec 3, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
Sam Kant1, Steven P Menez1, Mohamed Hanouneh1,2
1Department of Medicine, Johns Hopkins School of Medicine, 5601 Loch Raven Boulevard, Suite 3 North, Baltimore, MD, 21205, USA.
Insights
Coronavirus disease 2019 (CoVID-19) frequently causes acute kidney injury (AKI) in severe cases, leading to worse outcomes. Management of chronic kidney disease and kidney transplant patients requires careful monitoring during the pandemic.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- The coronavirus disease 2019 (CoVID-19) pandemic has presented unprecedented global health challenges.
- CoVID-19 impacts multiple organ systems, with acute kidney injury (AKI) being a significant complication in critically ill patients.
- Kidney transplant recipients, often on immunosuppression, may face heightened susceptibility and mortality risks from CoVID-19.
Purpose of the Study:
- To summarize the impact of CoVID-19 on kidney function and patients with kidney diseases.
- To review the incidence, mechanisms, and management strategies for AKI in CoVID-19 patients.
- To highlight considerations for chronic kidney disease and kidney transplant recipients during the pandemic.
Main Methods:
- Review of international studies and clinical observations regarding CoVID-19 and kidney injury.
- Elucidation of various patterns and mechanisms contributing to AKI in CoVID-19.
- Analysis of consequences on longitudinal management of chronic kidney disease and end-stage kidney disease patients.
Main Results:
- CoVID-19 is associated with a high incidence of AKI, particularly in critical care settings, correlating with worse patient outcomes.
- Variable incidence rates of AKI are reported globally, but consistently poor outcomes are noted in severe cases.
- Novel strategies for renal replacement therapy and adjustments in immunosuppression for transplant recipients have been explored.
Conclusions:
- Acute kidney injury is a major complication of CoVID-19, necessitating vigilant monitoring and management.
- Longitudinal care for patients with chronic kidney disease and end-stage kidney disease requires adaptation during the pandemic.
- Recommendations include increased disease surveillance, early testing, and tailored immunosuppression adjustments for kidney transplant recipients.
Abstract:
The pandemic of coronavirus disease 2019 (CoVID-19) has been an unprecedented period. The disease afflicts multiple organ systems, with acute kidney injury (AKI) a major complication in seriously ill patients. The incidence of AKI in patients with CoVID-19 is variable across numerous international studies, but the high incidence of AKI and its associated worse outcomes in the critical care setting are a consistent finding. A multitude of patterns and mechanisms of AKI have been elucidated, and novel strategies to address shortage of renal replacement therapy equipment have been implemented. The disease also has had consequences on longitudinal management of patients with chronic kidney disease and end stage kidney disease. Kidney transplant recipients may be especially susceptible to CoVID-19 as a result of immunosuppression, with preliminary studies demonstrating high mortality rates. Increased surveillance of disease with low threshold for testing and adjustment of immunosuppression regimen during acute periods of illness have been recommended.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Kidney Transplant I: Introduction
Chronic Kidney Disease II: Clinical Manifestations

